ProUroCare Medical Documents
Documents
100
Ticker
PUMD
ISIN
US74373C2061
ProUroCare Medical SEC Filings
ProUroCare Medical Documents 2026
This page contains all official documents and SEC filings for ProUroCare Medical stock (PUMD, ISIN: US74373C2061). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 100 documents are available. Data is updated regularly to provide investors with a complete overview of ProUroCare Medical's regulatory filings.
ProUroCare Medical Stock analysis
ProUroCare Medical ProUroCare Medical Inc, based in Eden Prairie, US, develops medical devices for prostate disease detection and characterization. The company focuses on the ProUroScan System, an imaging device that creates real-time elasticity images of the prostate using a rectal probe and specialized software. This system aids in visualizing abnormalities detected during digital rectal exams, offering two- and three-dimensional imaging capabilities. With a small team of two employees, ProUroCare operates in the Health Care sector, specializing in diagnostic tools for prostate health.